These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2149655)

  • 21. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E; Rickels K; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing impairment in patients with panic disorder: the Sheehan Disability Scale.
    Leon AC; Shear MK; Portera L; Klerman GL
    Soc Psychiatry Psychiatr Epidemiol; 1992 Mar; 27(2):78-82. PubMed ID: 1594977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sequence of improvement of the symptoms encountered in patients with panic disorder.
    Deltito JA; Argyle N; Buller R; Nutzinger D; Ottosson JO; Brandon S; Mellergard M; Shera D
    Compr Psychiatry; 1991; 32(2):120-9. PubMed ID: 2022110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA; Argyle N; Klerman GL
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report.
    Sheehan DV; Raj AB; Sheehan KH; Soto S
    Pharmacol Biochem Behav; 1988 Apr; 29(4):815-7. PubMed ID: 3413203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
    Cowley DS; Dager SR; Roy-Byrne PP; Avery DH; Dunner DL
    Biol Psychiatry; 1991 Jul; 30(1):49-56. PubMed ID: 1892962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB; Laraia MT; Ballenger JC; Howell EF
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Ballenger JC; Burrows GD; DuPont RL; Lesser IM; Noyes R; Pecknold JC; Rifkin A; Swinson RP
    Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS; Woods SW
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.
    Rickels K; Downing R; Schweizer E; Hassman H
    Arch Gen Psychiatry; 1993 Nov; 50(11):884-95. PubMed ID: 8215814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placebo response in panic disorder.
    Coryell W; Noyes R
    Am J Psychiatry; 1988 Sep; 145(9):1138-40. PubMed ID: 3046384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential treatment of panic disorder with alprazolam and imipramine.
    Goldstein S
    Am J Psychiatry; 1986 Dec; 143(12):1634. PubMed ID: 3789226
    [No Abstract]   [Full Text] [Related]  

  • 36. Concordance between self-reported and observer-rated anxiety severity in outpatients with anxiety disorders: The Leiden routine outcome monitoring study.
    Schat A; van Noorden MS; Giltay EJ; Noom MJ; Vermeiren RRJM; Zitman FG
    Psychol Psychother; 2017 Dec; 90(4):705-719. PubMed ID: 28737269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL
    J Psychiatr Res; 1990; 24 Suppl 2():27-41. PubMed ID: 1980697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How "blind" are double-blind studies?
    Margraf J; Ehlers A; Roth WT; Clark DB; Sheikh J; Agras WS; Taylor CB
    J Consult Clin Psychol; 1991 Feb; 59(1):184-7. PubMed ID: 2002136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.